The healthcare analytics firm adjusts its 2026 revenue outlook following the divestiture of its Vitalware unit.
Health Catalyst expects 2026 revenue between $246M and $249M after divesting its Vitalware business unit. The revised guidance reflects the impact of the sale on its financial outlook for the year.
The company previously provided revenue projections without the divestiture context. The updated range aligns with its strategic shift to focus on core analytics operations. No prior consensus estimates were publicly disclosed for comparison.
Management discussed the outlook during its Q2 2026 earnings call, emphasizing operational adjustments post-divestiture.